EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Why is early detection of colon cancer still not possible in 2023?

Valeria Tonini, Manuel Zanni

World Journal of Gastroenterology · 21.01.2024 · 30 (3) · 211-224

DOI: 10.3748/wjg.v30.i3.211 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift World Journal of Gastroenterology, online erschienen am 21.01.2024. Verfasst von Valeria Tonini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna 40138, Italy. valeria.tonini@unibo.it. Hauptthemen laut MEDLINE: Colonic Neoplasms, Colorectal Neoplasms, Rectal Neoplasms. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) screening is a fundamental tool in the prevention and early detection of one of the most prevalent and lethal cancers. Over the years, screening, particularly in those settings where it is well organized, has succeeded in reducing the incidence of colon and rectal cancer and improving the prognosis related to them. Despite considerable advancements in screening technologies and strategies, the effectiveness of CRC screening programs remains less than optimal. This paper examined the multifaceted reasons behind the persistent lack of effectiveness in CRC screening initiatives. Through a critical analysis of current methodologies, technological limitations, patient-related factors, and systemic challenges, we elucidated the complex interplay that hampers the successful reduction of CRC morbidity and mortality rates. While acknowledging the advancements that have improved aspects of screening, we emphasized the necessity of addressing the identified barriers comprehensively. This study aimed to raise awareness of how important CRC screening is in reducing costs for this disease. Screening and early diagnosis are not only important in improving the prognosis of patients with CRC but can lead to an important reduction in the cost of treating a disease that is often diagnosed at an advanced stage. Spending more sooner can mean saving money later.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsColorectal NeoplasmsRectal NeoplasmsHumansEarly Detection of CancerPrognosisMass ScreeningColonoscopy

Stichwörter der Autor:innen

Colon and rectal cancerColorectal cancerColorectal cancer screeningColorectal screening test

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, University of Bologna, Bologna 40138, Italy. valeria.tonini@unibo.it.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna 40138, Italy.

Zitieren

APA

Tonini, V., & Zanni, M. (2024). Why is early detection of colon cancer still not possible in 2023?. World Journal of Gastroenterology, 30(3), 211-224. https://doi.org/10.3748/wjg.v30.i3.211

Vancouver

Tonini V, Zanni M. Why is early detection of colon cancer still not possible in 2023?. World Journal of Gastroenterology. 2024;30(3):211-224. doi:10.3748/wjg.v30.i3.211

BibTeX
@article{Tonini2024,
  author = {Tonini, Valeria and Zanni, Manuel},
  title = {Why is early detection of colon cancer still not possible in 2023?},
  journal = {World Journal of Gastroenterology},
  year = {2024},
  volume = {30},
  number = {3},
  pages = {211--224},
  doi = {10.3748/wjg.v30.i3.211}
}
Kostenlos starten →